Accueil>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Nalidixic acid

Nalidixic acid (Synonyms: NSC 82174, WIN 18,320)

Catalog No.GC12455

L'acide nalidixique, un antibiotique quinolone, est efficace contre les bactéries gram-positives et gram-négatives.

Products are for research use only. Not for human use. We do not sell to patients.

Nalidixic acid Chemical Structure

Cas No.: 389-08-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
35,00 $US
En stock
50mg
48,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum.Target: AntibacterialNalidixic acid is the first of the synthetic quinolone antibiotics. Nalidixic acid is effective against both gram-positive and gram-negative bacteria. In lower concentrations, it acts in a bacteriostatic manner; that is, it inhibits growth and reproduction. In higher concentrations, it is bactericidal, meaning that it kills bacteria instead of merely inhibiting their growth. Nalidixic selectively and reversibly blocks DNA replication in susceptible bacteria. Nalidixic acid and related antibiotics inhibit a subunit of DNA gyrase and topoisomerase IV and induce formation of cleavage complexes. It also inhibits the nicking-closing activity on the subunit of DNA gyrase that releases the positive binding stress on the supercoiled DNA. From Wikipedia.

References:
[1]. http://en.wikipedia.org/wiki/Nalidixic_acid

Avis

Review for Nalidixic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nalidixic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.